July 19, 2022
Novavax’s COVID-19 vaccine cleared an important regulatory hurdle this afternoon.
During a daylong meeting, the CDC’s Advisory Committee on Immunization Practices (ACIP) unanimously recommended the vaccine, known as Adjuvanted, be available for people 18 and older. Next, CDC Director Rochelle Walensky will have to formally sign off on the recommendation before the vaccine can be administered to the public.
Here’s what you need to know:
HAP will continue to monitor the latest COVID-19 public health developments and provide updates to members. Learn more about the vaccine appointments available in your area.
A replay of the meeting, as well as the presentation materials, is available online. A fact sheet for health care providers also is online.
Tags: Public Health | COVID-19
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.